栝楼桂枝汤物质基准指纹图谱及关键质量属性量值传递规律研究<sup>*</sup>

刘珂, 吕贵杰, 王希琳, 谢玉和, 许文, 杨漪, 张勋, 林羽

doi:10.16155/j.0254-1793.2023-0694

药物分析杂志 >

2024 , Vol. 44 >Issue 7: 1125 - 1136

DOI: https://doi.org/10.16155/j.0254-1793.2023-0694

成分分析

栝楼桂枝汤物质基准指纹图谱及关键质量属性量值传递规律研究^*

展开

1.福建中医药大学药学院,福州350122;
2.福建中医药大学附属第二人民医院药剂科,福州 350003

第一作者 Tel:15259168640;E-mail:437671789@qq.com

^**张勋 Tel:(0591)22861135;E-mail:xunzhang716@163.com
林羽 Tel:(0591)22861980;E-mail:yulam@163.com

收稿日期: 2023-10-28

网络出版日期: 2024-08-05

基金资助

^*国家自然科学基金(81674046);福建中医药大学基础类学科科研提升计划(XJC2022007)

收起

HPLC fingerprint of substance benchmarks in Gualou Guizhi decoction and quantity transfer rule of key quality attributes^*

Expand

1. School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China;
2. Department of Pharmacy, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350003, China

Received date: 2023-10-28

Online published: 2024-08-05

Fold

摘要

目的:建立栝楼桂枝汤(Gualou Guizhi decoction)物质基准指纹图谱和多成分含量测定方法,探究饮片-物质基准关键质量属性的量值传递规律。方法:制备15批栝楼桂枝汤物质基准,采用ChromCore 120 C₁₈ (250 mm×4.6 mm,5 μm)色谱柱,以乙腈(A)-0.1%甲酸水(B)为流动相,进行梯度洗脱,流速0.8 mL·min^-1,柱温30 ℃,检测波长254 nm,采用中药色谱指纹图谱相似度评价软件(2012年版)建立指纹图谱,结合层次聚类分析(hierarchical cluster analysis, HCA)、主成分分析(principal component an alysis, PCA)与正交偏最小二乘法-判别分析(orthogonal partial least squares-discriminant analysis, OPLS-DA),筛选不同批次栝楼桂枝汤物质基准质量差异的主要化学成分。建立HPLC法测定主要差异性成分含量,以含量、出膏率和转移率分析栝楼桂枝汤的量值传递规律。结果:建立了栝楼桂枝汤物质基准HPLC指纹图谱,确定30个共有峰,与对照品比对共指认出其中9个成分,分别为没食子酸、芍药内酯苷、芍药苷、甘草苷、芒柄花苷、甘草素、肉桂酸、异甘草素、甘草酸。15批栝楼桂枝汤物质基准指纹图谱相似度均>0.920。3种化学识别模式均将样品分为2类,造成主要差异化学成分共5个,分别为甘草酸、甘草素、芍药苷、甘草苷、芒柄花苷。建立了多成分HPLC含量测定方法,符合方法学要求。饮片-物质基准之间5个差异成分的平均转移率分别为51.65%、40.46%、74.74%、60.06%、34.54%,平均出膏率为14.20%。结论:栝楼桂枝汤物质基准的关键质量属性在饮片-物质基准间稳定传递。建立的栝楼桂枝汤指纹图谱和含量测定方法准确、可靠,可为栝楼桂枝制剂的质量控制提供技术参考。

关键词： 栝楼桂枝汤; 物质基准; 指纹图谱; 量值传递; 高效液相色谱; 甘草酸; 甘草素; 芍药苷; 甘草苷; 芒柄花苷

本文引用格式

刘珂, 吕贵杰, 王希琳, 谢玉和, 许文, 杨漪, 张勋, 林羽 . 栝楼桂枝汤物质基准指纹图谱及关键质量属性量值传递规律研究^*[J]. 药物分析杂志, 2024 , 44(7) : 1125 -1136 . DOI: 10.16155/j.0254-1793.2023-0694

Abstract

Objective: To establish a fingerprint of Gualou Guizhi decoction and a method for determination of multi-component to clarify the transfer rule of quantities and quality from decoction pieces and substance benchmarks. Methods: Fifteen batches of Gualou Guizhi decoction substance benchmarks were prepared and analyzed by the method of HPLC. Traditional Chinese medicine (TCM) Chromatographic Fingerprint Similarity Evaluation Software (2012) and hierarchical cluster analysis (HCA), principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) was used to evaluate the quality differences between batches of substance benchmarks, and screen the main chemical compositions that were led to quality discrepancy. The main differential components were determined by HPLC. And their contents, yields and transfer rates were analyzed for transfer rule of quantities and quality. Results: HPLC fingerprint of Gualou Guizhi decoction was established. A total of 30 common peaks in the fingerprint of Gualou Guizhi decoction substance benchmarks were assigned. Compared with the reference standards, 9 components were identified as gallic acid, albiflorin, paeoniflorin, liquiritin, ononin, liquiritigenin, cinnamic acid, isoliquiritigenin and glycyrrhizic acid. The similarities of 15 batches of Gualou Guizhi decoction substance benchmarks samples were all above 0.920. All of them were divided into two categories by three chemical recognition modes for 5 major differential components, including glycyrrhizic acid, liquiritigenin, paeoniflorin, iquiritin, and ononin. The HPLC was also applied to determine the contents of multi-components and the method validation results were good. The average transfer rates of five index components were 51.65%, 40.46%, 74.74%, 60.06%, and 34.54%, respectively and their average extraction rate was 14.20%. Conclusion: The critical quality properties of Gualou Guizhi decoction can be stably transferred from decoction pieces to substance benchmarks. The method of fingerprint and content determination is accurate and reliable, which is able to provide technique for quality control of Gualou Guizhi decoction formulation.

Key words： Gualou Guizhi decoction; substance benchmark; fingerprint; quantity-value transmission; HPLC; glycyrrhizic acid; liquiritigenin; paeoniflorin; iquiritin; ononin

参考文献

[1] 田文熙. 《金匮要略》中桂枝汤类方调和阴阳的作用[J]. 中国中医基础医学杂志, 2010, 16(8):646
TIAN WX. Effects of harmonizing Ying-Yang with Gui Zhi Tang family of Formulae from Jin Kui Yao Lue [J]. Chin J Basic Med Tradit Chin Med, 2010, 16(8):646
[2] 张仲景·汉. 金匮要略[M]. 北京: 中医古籍出版社, 1977: 42
ZHANG ZJ·Han Dynasty. Jingui Yaolue[M]. Beijing: Publishing House of Ancient Chinese Medical Books, 1977: 42
[3] ZHANG J, HAN J, ZOU J, et al. Gualou Guizhi decoction improves glucose metabolism and alleviates microglia-associated inflammation after cerebral ischemia[J]. Evid Based Complement Alternat Med, 2022, 2022: 12
[4] ZHANG Y, CAO Y, LI Y, et al. Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR₂₁₀/HIF/VEGF pathway in vivo and in vitro[J]. Pharm Biol, 2023, 61(1):779
[5] 陈瑛玲, 陈立典, 陶静. 栝楼桂枝汤治疗中风后肢体痉挛的临床研究[J]. 中医临床研究, 2013, 5(4):7
CHEN YL, CHEN LD, TAO J. Clinical research on treating limbs spasm from cerebral apoplexy with the Gualou Guizhi decoction[J]. Clin J Chin Med, 2013, 5(4):7
[6] 曹桂云, 宁波, 庄雪松, 等. 基于标准汤剂的蔓荆子配方颗粒质量标准研究[J]. 中成药, 2023, 45(8):2484
CAO GY, NING B, ZHUANG XS, et al. Quality standard for Manjingzi formula granules based on standard decoction[J]. Chin Tradit Pat Med, 2023, 45(8):2484
[7] 王永春, 董金香, 李军鸽, 等. UPLC-Q-TOF/MS技术结合UNIFI数据库快速分析经典名方温经汤标准汤剂的化学成分[J]. 沈阳药科大学学报, 2022, 39(6):639
WANG YC, DONG JX, LI JG, et al. Rapid analysis of chemical components of Wenjing decoction standard decoction based on UPLC-Q-TOF/MS technology combined with UNIFI database[J]. J Shenyang Pharm Univ, 2022, 39(6):639
[8] 麻利杰, 姚静, 路露, 等. 中药配方颗粒汤剂与传统汤剂一致性评价存在的问题及建议[J]. 医药导报, 2023, 42(7):1039
MA LJ, YAO J, LU L, et al. Problems and suggestions in the consistency evaluation of granule decoction and traditional decoction of traditional Chinese medicine[J]. Her Med, 2023, 42(7):1039
[9] 童欢, 张明伟, 张炳武, 等. 基于指纹图谱、含量测定和化学模式识别的五子衍宗丸质量评价研究[J]. 药物分析杂志, 2023, 43(1):103
TONG H, ZHANG MW, ZHANG BW, et al. Study on quality evaluation of Wuziyanzong pills based on HPLC fingerprint, assay and chemical pattern recognition[J]. Chin J Pharm Anal, 2023, 43(1):103
[10] LV X, FENG S, ZHANG J, et al. Application of HPLC fingerprint combined with chemical pattern recognition and multi-component determination in quality evaluation of Echinacea purpurea (L.)[J]. Molecules, 2022, 27(19):6463
[11] 岳超, 徐普, 张文婷, 等. 基于HPLC指纹图谱和多指标成分含量测定及化学模式分析的玉屏风丸的质量评价[J]. 药物分析杂志, 2022, 42(11):2019
YUE C, XU P, ZHANG WT, et al. Quality evaluation of Yupingfeng pills based on HPLC fingerprint and determination of multi-index components and chemometrics analysis[J]. Chin J Pharm Anal, 2022, 42(11):2019
[12] XU W, HUANG M, LI H, et al. Chemical profiling and quantification of GuaLou GuiZhi decoction by high mass spectrometry and ultra-performance liquid chromatography/triple quadrupole mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 986-987: 69
[13] 李煌, 乔丽菲, 张玉琴, 等. 基于化学成分和生物效应的栝楼桂枝汤质量评价研究[J]. 中国中药杂志, 2017, 42(10):1877
LI H, QIAO LF, ZHANG YQ, et al. Quality evaluation of Gualou Guizhi decoction based on chemical compositions and biological effects[J]. China J Chin Mater Med, 2017, 42(10):1877
[14] 孙承韬, 张玉琴, 许文, 等. 栝楼桂枝颗粒质量标准研究[J]. 江西中医药, 2017, 48(8):58
SUN CT, ZHANG YQ, XU W, et al. Study on the quality standards of Gualou Guizhi granules[J]. Jiangxi J Tradit Chin Med, 2017, 48(8):58
[15] 仝小林. 方药量效学[M]. 北京: 中国中医药出版社, 2019: 144
TONG XL. Dosimetry of Prescriptions[M]. Beijing: China Traditional Chinese Medicine Publishing House, 2019: 144
[16] 仝小林, 穆兰澄, 姬航宇, 等. 《伤寒论》药物剂量考[J]. 中医杂志, 2009, 50(4):368
TONG XL, MU LC, JI HY, et al. Study on the dosage of medicines in treatise on Febrile Diseases[J]. J Tradit Chin Med, 2009, 50(4):368
[17] 杨春梅, 陈立典, 陶静. 古方今用瓜蒌桂枝汤[J]. 辽宁中医杂志, 2012, 39(8):1599
YANG CM, CHEN LD, TAO J. Ancient and modern Gualou Guizhi decoction[J]. Liaoning J Tradit Chin Med, 2012, 39(8):1599
[18] 医疗机构中药煎药室管理规范.第四章[S]. 2009
Standard Management of Traditional Chinese Medicine Decocting Rooms in Medical Institutions. 4th Chapter[S]. 2009
[19] 孙立丽, 王萌, 任晓亮. 化学模式识别方法在中药质量控制研究中的应用进展[J]. 中草药, 2017, 48(20):4339
SUN LL, WANG M, REN XL. Application progress on chemical pattern recognition in quality control of Chinese materia medica[J]. Chin Tradit Herb Drugs, 2017, 48(20):4339
[20] LIANG G, YANG J, LIU T, et al. A multi-strategy platform for quality control and Q-markers screen of Chaiqin Chengqi decoction[J]. Phytomedicine, 2021, 85: 153525
[21] LO HY, LI TC, YANG TY, et al. Hypoglycemic effects of Trichosanthes kirilowii and its protein constituent in diabetic mice: the involvement of insulin receptor pathway[J]. BMC Complement Altern Med, 2017, 17(1):53
[22] KONDO T, MIZUKAMI H, TAKEDA T, et al. Amino acid sequences and ribosome-inactivating activities of karasurin-B and karasurin-C[J]. Biol Pharm Bull, 1996, 19(11):1485
[23] WANG PC, WANG SX, YAN XL, et al. Combination of paeoniflorin and calycosin-7-glucoside alleviates ischaemic stroke injury via the PI3K/AKT signalling pathway[J]. Pharm Biol, 2022, 60(1):1469
[24] LIU YF, ZHANG L, WU Q, et al. Paeoniflorin ameliorates ischemic injury in rat brain via inhibiting cytochrome c/caspase3/HDAC4 pathway[J]. Acta Pharmacol Sin, 2022, 43(2):273
[25] YAN S, FANG C, CAO L, et al. Protective effect of glycyrrhizic acid on cerebral ischemia/reperfusion injury via inhibiting HMGB1-mediated TLR4/NF-κB pathway[J]. Biotechnol Appl Biochem, 2019, 66(6):1024
[26] ZHU K, ZHU X, LIU S, et al. Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1/GPX4 Pathway[J]. Oxid Med Cell Longev, 2022, 2022: 18
[27] SUN YX, TANG Y, WU AL, et al. Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties[J]. J Asian Nat Prod Res, 2010, 12(12):1051
[28] FU S, GU Y, JIANG JQ, et al. Calycosin-7-O-β-D-glucoside regulates nitric oxide/caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury[J]. J Ethnopharmacol, 2014, 155(1):692
[29] 中华人民共和国药典2020年版. 一部[S]. 2020: 23, 57, 88, 108, 104, 288
ChP 2020. Vol Ⅰ[S]. 2020: 23, 57, 88, 108, 104, 288
[30] 万鑫浩, 朱卫丰, 杨丽娜, 等. 经典名方桂枝加葛根汤的基准样品量值传递分析[J]. 中国中药杂志, 2022, 47(9):2430
WAN XH, ZHU WF, YANG LN, et al. Quality value transfer of material benchmark of Guizhi Jia Gegen decoction[J]. China J Chin Mater Med, 2022, 47(9):2430

Options

文章导航

模态框（Modal）标题

摘要

本文引用格式

Abstract

参考文献